Free provider profile
PEDRO DURAN
NPI 1942664842
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2018-07-17.
401 PARNASSUS AVE # 984, SAN FRANCISCO, CA, 94143
415-476-7527
Single practice location
Enumerated 2016-04-07
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 taxonomies listed — broader service mix.
- — Record last updated 8 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
282
Medicare patients
Not published
Part D drug cost
$21,195
Brand-name share
7.8%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Belsomra (Suvorexant) | 11 | $4,657 |
| Duloxetine Hcl (Duloxetine Hcl) | 20 | $521 |
| Dextroamphetamine-Amphet Er (Dextroamphetamine/Amphetamine) | 12 | $375 |
| Quetiapine Fumarate (Quetiapine Fumarate) | 18 | $369 |
| Propranolol Hcl (Propranolol Hcl) | 12 | $357 |
| Lorazepam (Lorazepam) | 33 | $275 |
| Lithium Carbonate (Lithium Carbonate) | 16 | $118 |
| Zolpidem Tartrate (Zolpidem Tartrate) | 16 | $116 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024103 sessions · 21 patients · $136,855
2023110 sessions · 17 patients · $138,620
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.